MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 63 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rise Advisors, LLC | 272 | $4,108 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 318,995 | $4,826,394 | 0.00% |
| Covestor Ltd | 106 | $0 | 0.00% |
| Farther Finance Advisors, LLC | 77 | $0 | 0.00% |
| JBF Capital, Inc. | 39,637 | $1,189 | 0.00% |
| GOLDMAN SACHS GROUP INC | 29,807 | $450,980 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 15 | $0 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 7,458 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 2,480 | $37,519 | 0.00% |